Skip to content

Drug interactions

Efavirenz + Ripretinib

Severity: Major

Efavirenz and Ripretinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may reduce ripretinib and its active metabolite exposure, potentially reducing efficacy in gastrointestinal stromal tumors.

What this interaction means in plain words

Efavirenz and Ripretinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Efavirenz belongs to Anti Virals; Ripretinib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction by efavirenz accelerates ripretinib metabolism.

What to do

Avoid the combination if possible and use a non-inducing antiretroviral. If unavoidable, monitor tumor response.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Ripretinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Ripretinib?

MediHelp rates the interaction as major. Efavirenz and Ripretinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Efavirenz may reduce ripretinib and its active metabolite exposure, potentially reducing efficacy in gastrointestinal stromal tumors.

How serious is the interaction between Efavirenz and Ripretinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible and use a non-inducing antiretroviral. If unavoidable, monitor tumor response.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in